secwatch.observer — SEC 8-K summary
======================================

Issuer:     HALOZYME THERAPEUTICS, INC. (HALO)
CIK:        0001159036
Form:       8-K
Filed at:   2023-02-23T23:59:59+00:00
Accession:  0001159036-23-000014
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director James M. Daly to resign from Halozyme board at end of 2023
-------------------------------------------------------------------

- James M. Daly notified Halozyme of his resignation from the Board, effective December 31, 2023.
- Resignation is not due to any disagreement with the Company, its operations, strategy, management, or Board.
- Mr. Daly's departure is planned nearly a year in advance, allowing for orderly succession.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1159036/000115903623000014/0001159036-23-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1159036/000115903623000014/halo-20230222.htm
  HTML page:      https://secwatch.observer/filing/0001159036-23-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer